Use antivenomics to map and license cross-neutralization of existing products against orphan species
#00135
Systematically test which existing polyvalent antivenoms already neutralize orphan-species venoms via antivenomics and preclinical assays, then pursue label extensions — expanding effective coverage without developing new products.
Liverpool School of Tropical Medicine, UK (venoms sourced from 13 sub-Saharan African countries)
OngoingLiverpool School of Tropical Medicine (Centre for Snakebite Research & Interventions) and collaborators · Region
Rather than develop a new product, researchers tested whether an existing polyvalent antivenom (PANAF-Premium, Premium Serums & Vaccines) already neutralizes the venoms of medically important sub-Saharan African snakes…
Orphan species (no specific product) assessed14species
Sub-Saharan African countries covered13countries
1 source